Cytokines are considered to be important mediators in the pathophysiology of sepsis and septic shock. We investigated if continuous arteriovenous haemofiltration (CAVH) could be used to remove excessive amounts of the cytokines tumour necrosis factor-ex (TNFex), interleukin (/L)-Iex and /L-6 from peripheral blood in critically ill patients. Nine septic patients with renal failure were treated with CAVH. Ultrafittrate and plasma were tested for cytokines by ELISA. All patients had detectable TNFex and IL-6 plasma levels, ranging from /0-750 pg/ml and 575 pg/ml, respectively. TNFex was removed by the ultrafittrate with concentrations ranging from /0-1,000 pg/ml. The TNFex levels were significantly higher in the ultrafittrate samples than in the corresponding plasma samples (P< 0.003).
Sepsis, complicated by multi-organ failure (MOF) and shock, is a major clinical problem. Despite treatment with more effective antibiotics and new technology for supportive care, the mortality is still above 60070. I. ' Haemodynamic instability is common in these patients and exacerbated by haemodialysis in those with renal insufficiency. Therefore, continuous arteriovenous haemofiltration (CAVH) has been used as an alternative to conventional haemodialysis. l' CAVH has minimal cardiovascular side-effects, even in patients receiving vasopressor drugs, because of the continuous slow removal of intravascular water, electrolytes and "toxic" metabolites.
It has been suggested that CAVH reverses cardiac dysfunction during sepsis by removal of a circulating filtrable myocardial depressant factor. 5 However, the chemical nature of this or other factors which may be removed by ultrafiltration has not yet been determined. '.6 Cytokines are believed to be important mediators in the pathophysiology of sepsis and septic shock. The most important cytokines in this regard, interleukin (lL)-lo:, IL-6 and tumour necrosis factor-o: (TNFo:), originate primarily from activated monocytes and macrophages. 7H ., They are all potent endogenous pyrogens and elicit a variety of biological responses including hepatic acute phase protein synthesis, anorexia, cachexia, leucocytosis, hypotension, disseminated intravascular coagulation (DIC) and shock. Several studies have demonstrated increased serum/ plasma levels of TNFo:, IL-Io: and IL-6 in septic patients. IIIIl The aim of the present study was to investigate whether CAVH could be used to remove excessive amounts of the cytokines TNFo:, IL-Io: and IL-6 from peripheral blood in critically ill patients with septic shock and MOF.
PATIENTS AND METHODS
Nine consecutive, critically ill septic patients with acute oliguric renal failure were treated with CAVH in the intensive care unit (lCU) at Od en se University Hospital. The study was approved by the Regional Ethical Committee on Human Research and informed consent was obtained from the patient or a close relative.
At the time of admission to the ICU, all patients had developed sepsis according to the definition of Bone as sepsis with evidence of inadequate organ perfusion/function of at least two organs. 14 Septic shock was defined as the sepsis syndrome with haemodynamic instability requiring intravascular volume expansion as well as vasoactive and inotropic drugs to maintain a systolic blood pressure > 90 mmHg. Refractory septic shock was defined as hypotension not responsive to intravenous fluids or pharmacological intervention.
All the patients were treated with fluid resuscitation, antibiotics and vasopressor agents (dobutamine, noradrenaline, adrenaline); two patients received additional vasodilators. Low-dose dopamine (2-4 j.tg/kg/min) was given to maintain renal perfusion. Total parenteral nutrition was administered to all patients. A pulmonary artery Swan-Ganz catheter was inserted into all patients, and ventilation was performed by a Servo ventilator 900C (Siemens). The patients received from 40 to 50 per cent oxygen.
CAVH
A polysulphone hollow-fibre filter with a cut-off point of 30kD (Fresenius, Ultraflux AV600) was used. Vascular access was obtained by cannulation of the femoral artery and vein. Heparin infusion into the arterial line was adjusted to maintain an Activated Partial Thromboplastin Time (APTT) in peripheral venous blood of twice the baseline value.
Net ultra filtrate volumes were between 400-750 mllhour, with great inter-and intraindividual variation. The ultrafiltrate was replaced by an intravenously administered lactate-buffered infusate at volumes sufficient to maintain desired cardiovascular indices.
Cytokine analyses
Venous blood samples were collected in EDTA/Trasylol® tubes on admission to the ICU and daily between 9 and 11 a.m. Ultrafiltrate samples and blood samples were simultaneously collected during CAVH treatment. Blood samples were immediately refrigerated on ice and plasma was isolated by centrifugation at 1500 rpm for 10 minutes. The plasma and ultrafiltrate samples were subsequently stored at -80 Q C until assay. Cytokine concentrations in plasma and ultrafiltrate were measured by double-sandwich ELISAs using specific polyclonal rabbit antibodies to recombinant IL-l a, TNFa and IL-6, respectively. 15.16 Immuno-maxisorp plates 96-well (Nunc, Roskilde, Denmark) were coated with Protein-A affinity-purified IgG. Non-attached sites were blocked with 5070 human Anaesthesia and Intensive Care, Vol. 21, No. 6, December, 1993 serum albumin in phosphate buffer saline (PBS). Plasma samples were diluted in PBS-buffer supplemented with 10% normal rabbit serum (Dako, Glostrup, Denmark), EDTA 10 mmolll, Aprotinin 2,000 KIE/ml, DL-dithiotreitol 5 mmoll!. Human natural cytokines obtained by lipopolysaccharidestimulation of heparinized whole blood were used for calibrations along with interim international standards of recombinant cytokines (National Institute for Biological Standards and Controls, Potters Bar, Hertfordshire, U.K.). Biotinylated polyclonal rabbit antibodies were used as detecting antibodies along with streptavidin-peroxidase (Kirkegaard and Perry La., Gaithersburg, MD, USA). Developments were carried out with 1,2-phenylendiamine dihydrochloride and measured at 492 nm. The interassay coefficient of variance and the intraassay coefficient of variance for the concentration range between 0.3 and 5 ng/ml were less than 12%. The sensitivities of the ELISAs for cytokines in plasma were 10-30 pg/m!. 16 
Statistical analysis
Comparisons were made with Wilcoxon's signed ranks test.
RESULTS
Patient characteristics, diagnosis, complications and clinical outcome are presented in Table 1 . The mean age was 47 years (range 31-69 years). All patients developed septic shock and MOF. Seven patients (78%) died in refractory septic shock. Eight patients were treated with CAVH for three to seven days, while one patient (No. 9) was treated for 15 days.
All patients had detectable TNFa and IL-6 plasma levels, ranging from 10 to 750 pg/ml and 50-4,575 pg/ml, respectively. There was considerable interindividual variation, but limited intraindividual dayto-day variation.
TNFa was removed by the ultrafiltrate, with concentrations in the filtrates ranging from 10 to 1,000 pg/m!. The TNFa levels were significantly higher in the ultrafiltrate samples than in the corresponding plasma samples (P<0.003). IL-6 was undetectable in the ultrafiltrate from five of the patients despite concomitant high plasma levels. IL-la was detectable in plasma in four patients (range 10-800 pg/mi); in all four patients IL-la was detectable also in the ultrafiltrates.
Two patients underwent haemodialysis. In patient No. 4, haemodialysis elicited severe haemodynamic instability, and CAVH was therefore started. In patient No. 9, haemodialysis was started after a period of five days on CAVH because CAVH was insufficient to control uraemia and acidosis. 
DISCUSSION
Recent clinical studies have suggested that CAVH, sometimes supplemented by plasmaphaeresis or dialysis, favourably influences the clinical course of patients with sepsis and MOF. 1719 Others have suggested that CAVH improves haemodynamic and metabolic variables and pulmonary gas exchange during septic or cardiogenic shock. '.20.21 These possible beneficial effects have been ascribed to clearance from plasma of "toxic" substances, including myocardial depressant substances such as cytokines. In a recent study it was demonstrated that haemofiltration improved cardiac performance in endotoxin-induced shock in pigs and this could be explained by the removal of mediators responsible for myocardial depression. 22 The major finding of this study was that the cytokines TNFa and IL-6, which have been implicated in the pathogenesis of MOF, were found at appreciable concentrations in plasma in all patients, while IL-la was detectable in only four of the nine patients. Both IL-6, TNFa and IL-la were recovered in the ultrafiltrate during CAVH treatment. IL-6 was, however, undetectable in the ultrafiltrate from five of the patients despite concomitant high plasma levels.
During CAVH, blood flows through the haemofilter primarily because of the arterial-venous pressure gradient. The fibres in the haemofilter effectively permit removal of small-and medium-size plasma solutes while holding back proteins and blood cells. The cut-off point of the haemofilter used was about 30kD and molecules up to this size are allowed to be filtered, albeit at a slower rate than smaller molecules. This cut-off point is similar to that of other filters in common use.' The molecular weight of IL-6 is between 20-30kD, of IL-la 17kD and of TNFa between 17-50kD.9 Therefore, differences in molecular weight do not explain why TNFa and IL-la, but not IL-6, were recovered in the ultrafiltrate.
In our study, TNFa was present in septic patients whether the patients were infected with gram-negative or gram-positive bacteria. This is in accordance with the findings of other investigators. 10 A potentially important finding in our study was that L I i 15 16 FIGURE la: TNFa concentrations.
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FIGURES la, Ib, lc: TNFo; lL-la and IL-6 concentrations in plasma. and ultrafiltrate Il!l in nine septic patients (1-9) undergoing continuous arteriovenous haemofiltration (CAVH). During CAVH treatment D ultrafiltrate and plasma were tested daily for cytokines. In patient No. 4 haemodialysis (HO) elicited haemodynamic instability and CAVH was started. In the same patient, the very high plasma IL-6 concentration is shown as ng/ml. In patient No. 8, HO was started after a period of five days with CAVH. tindicates death of the patient.
IL-1a
Pt TNFc¥ was detectable in the ultrafiltrate at a higher concentration than that in the simultaneously drawn plasma sample. The reason for this is unknown. However, antibodies and soluble receptors to TNFcx, IL-lc¥, and IL-6 may transport cytokines in the circulation, possibly in biologically inactive and/or immunochemically undetectable forms. 21 It is possible that passage through the haemofilter may cause the release of cytokines into the ultrafiltrate in an active and biochemically detectable form.
Another explanation for the higher concentration of TNFc¥ in ultrafiltrate than in plasma could be activation of circulating macrophages, the primary source of TNFcx, on the membranes of the haemofilter itself. Further studies are needed to clarify this.
There are only a few clinical studies on the value of CAVH in the treatment of septic shock complicated by acute renal failure. IR This study was not designed to be an interventional study and no attempt was therefore made to look at patient outcome. CAVH was started rather late when renal failure had developed in patients with septic shock and at this stage of the disease course the mortality is already very high. 24 A favourable effect and ultimate survival with the removal of cytokines by CAVH should be investigated in an animal sepsis model, where treatment with CAVH is started early. 
